Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -98,963 | -66,376 | -30,021 | -127,847 | -91,540 |
| Depreciation Amortization | -1,160 | -861 | -580 | -6,996 | -5,666 |
| Other Working Capital | -7,123 | -9,266 | -8,486 | 1,968 | -2,412 |
| Other Operating Activity | 18,759 | 13,128 | 6,554 | 20,213 | 15,010 |
| Operating Cash Flow | $-88,487 | $-63,375 | $-32,533 | $-112,662 | $-84,608 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -164,530 | -54,030 | 22,837 | 23,325 | -19,549 |
| PPE Investments | -485 | -450 | -387 | -1,188 | -969 |
| Investing Cash Flow | $-165,015 | $-54,480 | $22,450 | $22,137 | $-20,518 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 246,161 | 134,969 | 253 | 126,715 | 126,140 |
| Other Financing Activity | -2,397 | -656 | -242 | -168 | -168 |
| Financing Cash Flow | $243,764 | $134,313 | $11 | $126,547 | $125,972 |
| Beginning Cash Position | 59,897 | 59,897 | 59,897 | 23,875 | 23,875 |
| End Cash Position | 50,159 | 76,355 | 49,825 | 59,897 | 44,721 |
| Net Cash Flow | $-9,738 | $16,458 | $-10,072 | $36,022 | $20,846 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,487 | -63,375 | -32,533 | -112,662 | -84,608 |
| Capital Expenditure | -485 | -450 | -387 | -1,188 | -969 |
| Free Cash Flow | -88,972 | -63,825 | -32,920 | -113,850 | -85,577 |